Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 53
Bristol-Myers Squibb Pulls Tequin Antibiotic Off the Market
Beyond the Headlines, Columns-Drugs & Supplements, May 2006
Fosamax: The Powers of Equity
Journal Top Ten, Columns-Drugs & Supplements, May 2006
Warnings, Columns-Drugs & Supplements, May 2006
Baycol Defendants Move to Exclude Expert's 'Junk Science' Testimony
Fosamax Parties Propose Order to Protect 'Confidential Information'
Initial CMO Signed in Tennessee Fosamax Case
